Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 155 No. 5 (2025)

Persistent opioid use among patients who underwent intermediate-to-major elective surgery at a Swiss cantonal hospital: a prospective cohort study

Cite this as:
Swiss Med Wkly. 2025;155:4152
Published
15.05.2025

Summary

STUDY AIM: To investigate the extent of persistent opioid use among patients undergoing intermediate-to-major elective surgery at a Swiss cantonal hospital and as a secondary aim to identify factors potentially predictive of persistent opioid use (6 to 12 weeks after surgery).

METHODS: For this single-centre prospective cohort study, all consecutive patients undergoing elective primary hip arthroplasty, partial or complete prostatectomy, caesarean delivery, spinal surgery, intermediate-to-major visceral surgery or major hand surgery were screened for enrolment from June 2022 to May 2023. We collected basic demographic and medical data, perioperative opioid use (converted to morphine milligram equivalents), postoperative complications, and opioid prescriptions issued by the hospital or other healthcare providers. Telephone interviews about opioid use were conducted with patients 6 weeks after surgery. Only those patients who were still taking opioids at the 6-week interview were contacted 12 weeks after surgery. The primary endpoint was the rate of persistent opioid use 6 or 12 weeks after surgery, and the secondary endpoints were (a) the percentage of patients who received and reported filling prescriptions, and (b) the type and amount of opioids dispensed. With persistent opioid use as the dependent variable, bivariate (predictors: pain or preoperative morphine milligram equivalent) and multivariate logistic regression models were used to assess associations (predictors: age, sex, ASA [American Society of Anesthesiologists] score, preoperative pain).

RESULTS: A total of 855 patients were included in the main analysis. Median age was 62 years (interquartile range [IQR] 45–73), 52% were male and postsurgical complications occurred in 51 patients (6%). Fifty-six patients (7%) were preoperative opioid users. At discharge, 40 patients (5%) received an opioid prescription. Of the 724 patients who completed the 6-week follow-up interview, 30 (4%) had filled an opioid prescription (17 hospital-issued, 9 from an external source and 4 from both). Of the 30 patients (4%) who took opioids, the median length of consumption was 7 days (IQR 3–18). Seventeen patients (2%, 9 preoperative users) were taking opioids after 6 weeks. Seven of these 724 patients (1%, 5 preoperative users) continued use at 12 weeks postoperatively. Bivariate logistic regression analyses showed preoperative pain levels (at rest and during movement) were associated with persistent opioid use (odds ratio [OR] 1.27, 95% confidence interval [CI]: 1.11–1.46, p = 0.001; OR 1.3, 95% CI: 1.12–1.5, p = 0.001, respectively), as were 6-week postoperative pain levels (OR 1.96, 95% CI: 1.61–2.39, p <0.0001; OR 1.82, 95% CI: 1.52–2.18, p <0.0001, respectively). The median preoperative morphine milligram equivalent of persistent opioid users was 60 (IQR 30–180) versus 22.5 (IQR 15–30) in non-persistent users (p = 0.0155). There was a slight positive association between higher preoperative morphine milligram equivalent dosage and persistent postoperative opioid use (OR 1.024, 95% CI: 1.003–1.0456, p = 0.023), with a 2.4% increase in the likelihood of prolonged use per morphine milligram equivalent unit. After controlling for potential confounding factors, multivariate logistic regression analyses indicated associations with higher ASA score (OR 11.8, 95% CI: 2.48–56.51, p = 0.002) and preoperative pain levels (OR 1.23, 95% CI: 1.05–1.43, p = 0.008).

CONCLUSIONS: Only a small proportion (1%) of surgical patients continued opioid use 12 weeks after intermediate-to-major elective surgery, with an even much lower proportion (0.3%) having been opioid-naive before surgery. This low rate of prolonged opioid use may be due to the restrictive prescription policy of the centre and local healthcare providers.

References

  1. Larach DB, Hah JM, Brummett CM. Perioperative Opioids, the Opioid Crisis, and the Anesthesiologist. Anesthesiology. 2022 Apr;136(4):594–608. doi: https://doi.org/10.1097/ALN.0000000000004109
  2. Callinan CE, Neuman MD, Lacy KE, Gabison C, Ashburn MA. The Initiation of Chronic Opioids: A Survey of Chronic Pain Patients. J Pain. 2017 Apr;18(4):360–5. doi: https://doi.org/10.1016/j.jpain.2016.11.001
  3. Humphreys K. Avoiding globalisation of the prescription opioid epidemic. Lancet. 2017 Jul;390(10093):437–9. doi: https://doi.org/10.1016/S0140-6736(17)31918-9
  4. Barreveld AM, Mendelson A, Deiling B, Armstrong CA, Viscusi ER, Kohan LR. Caring for Our Patients With Opioid Use Disorder in the Perioperative Period: A Guide for the Anesthesiologist. Anesth Analg. 2023 Sep;137(3):488–507. doi: https://doi.org/10.1213/ANE.0000000000006280
  5. Huang X, Keyes KM, Li G. Increasing Prescription Opioid and Heroin Overdose Mortality in the United States, 1999-2014: An Age-Period-Cohort Analysis. Am J Public Health. 2018 Jan;108(1):131–6. doi: https://doi.org/10.2105/AJPH.2017.304142
  6. Max MB; American Pain Society Quality of Care Committee. Quality improvement guidelines for the treatment of acute pain and cancer pain. JAMA. 1995 Dec;274(23):1874–80. doi: https://doi.org/10.1001/jama.1995.03530230060032
  7. Ladha KS, Neuman MD, Broms G, Bethell J, Bateman BT, Wijeysundera DN, et al. Opioid Prescribing After Surgery in the United States, Canada, and Sweden. JAMA Netw Open. 2019 Sep;2(9):e1910734. doi: https://doi.org/10.1001/jamanetworkopen.2019.10734
  8. Ruchat D, Suter MR, Rodondi PY, Berna C. [Opioid consumption from 1985 to 2015 : the situation in Switzerland, with an international comparison]. Rev Med Suisse. 2018 Jun;14(612):1262–6. doi: https://doi.org/10.53738/REVMED.2018.14.612.1262
  9. Müller D, Scholz SM, Thalmann NF, Trippolini MA, Wertli MM. Increased Use and Large Variation in Strong Opioids and Metamizole (Dipyrone) for Minor and Major Musculoskeletal Injuries Between 2008 and 2018: An Analysis of a Representative Sample of Swiss Workers. J Occup Rehabil. 2024 Mar;34(1):157–68. doi: https://doi.org/10.1007/s10926-023-10115-5
  10. Hooijman MF, Martinez-De la Torre A, Weiler S, Burden AM. Opioid sales and opioid-related poisonings in Switzerland: A descriptive population-based time-series analysis. Lancet Reg Health Eur. 2022 Jun;20:100437. doi: https://doi.org/10.1016/j.lanepe.2022.100437
  11. Gaertner K, Wildbolz S, Speidel V, Exadaktylos AK, Hautz WE, Müller M. Prevalence and practice of opioid prescription at a Swiss emergency department: 2013-2017. Swiss Med Wkly. 2020 Apr;150(1516):w20202. doi: https://doi.org/10.4414/smw.2020.20202
  12. Koepke EJ, Manning EL, Miller TE, Ganesh A, Williams DG, Manning MW. The rising tide of opioid use and abuse: the role of the anesthesiologist. Perioper Med (Lond). 2018 Jul;7(1):16. doi: https://doi.org/10.1186/s13741-018-0097-4
  13. Kharasch ED, Clark JD, Adams JM. Opioids and Public Health: The Prescription Opioid Ecosystem and Need for Improved Management. Anesthesiology. 2022 Jan;136(1):10–30. doi: https://doi.org/10.1097/ALN.0000000000004065
  14. Brandal D, Keller MS, Lee C, Grogan T, Fujimoto Y, Gricourt Y, et al. Impact of Enhanced Recovery After Surgery and Opioid-Free Anesthesia on Opioid Prescriptions at Discharge From the Hospital: A Historical-Prospective Study. Anesth Analg. 2017 Nov;125(5):1784–92. doi: https://doi.org/10.1213/ANE.0000000000002510
  15. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205–13. doi: https://doi.org/10.1097/01.sla.0000133083.54934.ae
  16. Spitalpharmazie Basel. Opioid-Rechner, Version 3.0, 2017. Available from: https://www.spitalpharmazie-basel.ch/dienstleistungen/opioide.php
  17. Brummett CM, Waljee JF, Goesling J, Moser S, Lin P, Englesbe MJ, et al. New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults. JAMA Surg. 2017 Jun;152(6):e170504. doi: https://doi.org/10.1001/jamasurg.2017.0504
  18. Kaafarani HM, Han K, El Moheb M, Kongkaewpaisan N, Jia Z, El Hechi MW, et al. Opioids After Surgery in the United States Versus the Rest of the World: The International Patterns of Opioid Prescribing (iPOP) Multicenter Study. Ann Surg. 2020 Dec;272(6):879–86. doi: https://doi.org/10.1097/SLA.0000000000004225
  19. Larsson V, Nordenson C, Karling P. Long-term postoperative opioid prescription after cholecystectomy or gastric by-pass surgery: a retrospective observational study. Scand J Pain. 2021 Apr;21(3):569–76. doi: https://doi.org/10.1515/sjpain-2020-0150
  20. Peahl AF, Dalton VK, Montgomery JR, Lai YL, Hu HM, Waljee JF. Rates of New Persistent Opioid Use After Vaginal or Cesarean Birth Among US Women. JAMA Netw Open. 2019 Jul;2(7):e197863. doi: https://doi.org/10.1001/jamanetworkopen.2019.7863
  21. Weiner SG. Addressing the ignored complication: chronic opioid use after surgery. BMJ Qual Saf. 2021 Mar;30(3):180–2. doi: https://doi.org/10.1136/bmjqs-2020-011841
  22. Ardeljan LD, Waldfogel JM, Bicket MC, Hunsberger JB, Vecchione TM, Arwood N, et al. Current state of opioid stewardship. Am J Health Syst Pharm. 2020 Apr;77(8):636–43. doi: https://doi.org/10.1093/ajhp/zxaa027
  23. Held U, Forzy T, Signorell A, Deforth M, Burgstaller JM, Wertli MM. Development and internal validation of a prediction model for long-term opioid use-an analysis of insurance claims data. Pain. 2024 Jan;165(1):44–53.
  24. Bonar EE, Coughlin L, Roche JS, Philyaw-Kotov ML, Bixler EA, Sinelnikov S, et al. Prescription opioid misuse among adolescents and emerging adults in the United States: A scoping review. Prev Med. 2020 Mar;132:105972. doi: https://doi.org/10.1016/j.ypmed.2019.105972